ebm.bmj2d
Opportunities, challenges and risks of using artificial intelligence for evidence synthesis
Artificial intelligence (AI) is developing rapidly. In particular, in the area of machine learning (ML), significant progress ...
ebm.bmj2d
Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis
Correspondence to Dr Preeti Malik, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; pmalik.ma{at}gmail.com Objective To evaluate association between biomarkers and outcomes in ...
ebm.bmj5d
Unknowns of drug company payment disclosure: why the UK needs payment transparency legislation
New government legislation is necessary to ensure full transparency of industry payments in the UK’s healthcare. A first step ...
ebm.bmj7d
Cholesterol paradox: a correlate does not a surrogate make
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...